Due to the reduced activity of the rate-limiting enzyme ferrochelatase, as well as iron deficiency in the tumor tissue, in contrast to the normal one, there is an accumulation of an intermediate product of biosynthesis–protoporphyrin IX (PP IX). The gene discussed is FECH; the disease is nutritional disorder.